Browse > Home / Breaking News / Advanced Healing Now Possible (OTC:DSCI)

Advanced Healing Now Possible (OTC:DSCI)

August 31, 2009

Advanced Healing Now Possible (OTC:DSCI)

StocksHaven Investments news entrance takes a closer look at Derma Sciences Inc. (OTC:DSCI), that hopes its mix with drugs, DSC127 will get the second FDA approved drug for Accelerated Wound Healing.

Derma Sciences is a in fact unique and very much undervalued company within the micro-cap biomed interval which publicly targets a prescription drug market that is about 5x its present place of traffic cap. The society is developing a patented topical deaden through narcotics for accelerated healing and cicatrix prevention and newly launched Advanced Wound Care products approaching $10M, including the exceedingly received MEDIHONEY, and BIOGUARD, both of which have garnered tremendeous success and continue to increase sales annually. The real germ but lies within their DSC127 appearance II pipeline drug. Derma Sciences reported that it continues to offer for consideration progressive with clinical trials of DSC127, what one. has the potential to be solitary the forward approved physic without interruption the market for accelerated wound healing, a market through over $100M in sales anually.

The full uncommon detail in succession the company appears at http://www.stockshaven.com/advanced-healing-now-possible-otcdsci/

Disclosure: Position in DSCI

To feature your publicly traded concourse in StocksHaven.com Alerts or for the reason that a fully profiled company, email us at michaelvlaicu@stockshaven.com

About StocksHaven Investments

StocksHaven Investments have power to exist construct at StocksHaven.com. It is a company offering a information portal covering the cosmos fiscal news and equities sector. It features its hold blog, free state of equality 2 quotes, pair custom linking capability, investment dictionary, standing research reports, conference calls, news feeds, mailing list, videos, press release brains, live-stock commentaries, company reviews and other unique content including expert live-stock analysis from Michael Vlaicu. The company also offers PR relations and contracting services.

For again financial and investment news, survey www.StocksHaven.com

Certain sections of this report contain forward-looking statements that are based on our reporters’ expectations, estimates, projections and assumptions. Words such being of the class who “expects” “anticipates” “plans” “believes” “scheduled” “estimates” and variations of these bickering and similar expressions are intended to identify forward-looking statements, what one. include but are not limited to projections of revenues, income, section exhibition, cash flows, contract awards, FDA announcements, trial and drug approvals, and company durability. Forward-looking statements are made pursuant to the safe harbor supplies of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of coming time act and inwrap certain risks and uncertainties, which are difficult to predict. Therefore, objective future results and trends may differ materially from what is forecast in forward-looking statements becoming to a variety of factors including but not limited to the status or issue of legal and/or regulatory proceedings.

All forward-looking statements speak sole as of the date of this report or, in the process of any writing incorporated by allusion, the time of that writing. All succeeding written and oral forward-looking statements attributable to the fellowship or in any degree human frame acting on the company’sitting profit are qualified by the cautionary statements in this section. StocksHaven.Com does not agree some obligation to update or publicly loose some revisions to forward-looking statements to reflect events, circumstances or changes in expectations hinder the date of this common fame.

Written by Samanta · Filed Under Breaking News